The absence of MyD88 has no effect on the induction of alternatively activated macrophage during Fasciola hepatica infection by Luo, HongLin et al.
RESEARCH ARTICLE Open Access
The absence of MyD88 has no effect on the
induction of alternatively activated macrophage
during Fasciola hepatica infection
HongLin Luo
1*, Weiyi Huang
2, Dongying Wang
2,3, Haoju Wang
1 and Kui Nie
1
Abstract
Background: Alternatively activated macrophages (AAMj) play important roles in allergies and responses to
parasitic infections. However, whether signaling through toll-like receptors (TLRs) plays any role in AAMj induction
when young Fasciola hepatica penetrates the liver capsule and migrates through the liver tissue is still unclear.
Results: The data show that the lack of myeloid differentiation factor 88 (MyD88) has no effect on the AAMj
derived from the bone marrow (BMMj) in vitro and does not impair the mRNA expression of arginase-1, resistin-
like molecule (RELMa), and Ym1 in BMMjs. The Th2 cytokine production bias in splenocytes was not significantly
altered in F. hepatica-infected mice in the absence of MyD88 in vitro and in the pleural cavity lavage in vivo.I n
addition, MyD88-deficiency has no effect on the arginase production of the F. hepatica elicited macrophages (Fe
Mjs), production of RELMa and Ym1 proteins and mRNA expression of Ym1 and RELMa of macrophages in the
peritoneal cavity 6 weeks post F. hepatica infection.
Conclusions: The absence of MyD88 has no effect on presence of AAMj 6 weeks post F. hepatica infection.
Background
Macrophages are highly plastic cells that respond to
diverse environments by altering their phenotype and
physiology [1,2] and play important roles in both innate
and adaptive immunity. Currently, macrophages are
classified under two phenotypes, classically activated
macrophages (CAMF) and alternatively activated
macrophages (AAMF). CAMF are induced by inter-
feron-gamma (IFN-g) and lipopolysaccharide (LPS),
whereas induction of the AAMF phenotype is asso-
ciated with various stimuli, such as IL-4/IL-13, IL-10,
immunocomplexes, and glucocorticoids [2]. The most
widely studied stimuli for generating AAMF is treat-
ment with IL-4/IL-13 [1,3]. Although IL-4/IL-13 signal-
ing are essential to the presence of AAMF and both
cytokines have many overlapping activities on macro-
phages, they exhibit distinct functions because of their
specific receptor subunits aside from their shared com-
mon alpha chain [4]. However, this does not alter the
fact that a Th2-dominated environment is critical for
AAMF induction [5-7]. All helminths have been
demonstrated to induce profound Th2 responses, which
are characterized by the production of IL-4, IL-5, IL-9,
IL-10, and IL-13 by CD4
+ T cells [8], and this Th2-
dominated cytokine profile is associated with the pre-
sence of the AAMF phenotype (such as in Schistosoma
mansoni [9], Taenia crassiceps [10], Brugia malayi [11],
Heligmosomoides polygyrus [12], Nippostrongylus brasi-
liensis [13], and F. hepatica infection [14,15], and so
forth). AAMF are increasingly recognized as a key effec-
tor arm of the Th2 immunity, but their real function in
various helminth infections has not been illustrated and
is likely to be diverse. However, discovery of molecular
markers of AAMF, such as mannose receptor (CD206),
IL-10, arginase -1 (instead of inducible nitric oxide),
resistin-like molecule (RELMa), and Ym1 [6,16-19],
made the identification of AAMF possible. Among
them, three most abundant IL-4/IL-13 dependent genes:
Ym1, a member of the family 18 chitinases family but
with no chitinolytic activity [20], RELMa, was described
as FIZZ1 [21], and is identified as a cysteine-rich mole-
cule associated with resistin that is involved in glucose
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tion of nitric oxide (NO) production by competing with
iNOS for substrate L-arginine [23], suppression of T cell
responses via L-arginine depletion [24] and has been
currently accepted as a molecular signature for AAMF.
However, the functions of AAMF in helminth infections
have not been fully illustrated. Questions such as
whether AAMF promotes helminth killing or expulsion,
whether alternative activation requires anti-worm effec-
tor function, or whether signaling TLRs play a role in
AAMF induction, have not been fully answered.
In the current study, the role of TLRs in AAMF
induction during F. hepatica infection, which has been
observed to produce Th2-dominated responses in both
mice and the natural ruminant hosts [14,15] is investi-
gated using MyD88-deficient mice.
TLRs are pattern recognition receptors (PRRs) that
recognize different pathogen-associated molecular pat-
terns (PAMPs) [25]. TLR signaling is mostly MyD88-
dependent [26,27] except for TLR3 signaling, which
requires a TRIF adaptor [26,27]. Mice lacking MyD88
cannot respond to LPS [28]. The absence of MyD88 has
been demonstrated to have no effect on the augmenta-
tion of Th2 responses [29,30], which indicates that Th2
responses are elicited in a MyD88-independent manner.
However, contrary results have also demonstrated that
TLR signaling plays a role in Th2 responses [31]. Aside
from the required Th2 environment, especially with IL-
4/IL-13, the determinants of the AAMF phenotype
remain unclear. For F. hepatica infection, whether TLR
signaling is required for AAMF induction is unknown.
Therefore, whether AAMF could be induced without
MyD88 and whether TLR signals affect AAMj activa-
tion were investigated.
Results
Lacking of MyD88 has no impact on the presence of
AAMF derived from bone marrow
To determine whether MyD88 signaling is required for
AAMF induction, investigations were made to deter-
mine whether BMMj,c u l t u r e df r o mb o t hW Ta n d
MyD88 knockout mice, could be activated through this
approach. This is based on the fact that arginase-1 upre-
gulation, which is generally associated with Th2 cyto-
kines, such as IL-4 [32], is a feature of AAMFs. As a
control, iNOS, the enzyme associated with CAMFs, was
also detected [33]. BMMjs were treated with LPS and
IFN-g, either together or separately, or with media alone
for 20-24 h after overnight treatment with or without
IL-4. Subsequently, arginase-1 and iNOS enzyme activity
were measured (Figure 1). The results show both WT
and MyD88-/- BMMj cells displayed arginase activity in
response to IL-4 compared with the cells without IL-4
stimulation even though no statistically significant
differences were found between groups (Figure 1A). WT
BMMjs treated with LPS also exhibited arginase activity
and were absent in MyD88-/- mice. iNOS activity was
monitored by measuring nitrite concentrations in the
BMMj supernatant fluids using the Greiss reagent. The
results show that WT BMMjs (with or without IL-4 sti-
mulation) produced nitrite when stimulated with LPS
alone and with IFN-g. A synergistic effect was observed
on the iNOS activity with further upregulation when
treated with both LPS and IFN-g compared with LPS or
IFN-g treatment alone (Figure 1B). MyD88-/- BMMj
showed similar trend with WT BMMj on NO produc-
tion. However, almost no NO was detected upon stimu-
lation with LPS alone compared with WT BMMjs.
Moreover, NO could be produced via pretreatment with
IL-4 followed by stimulation with LPS alone. Treatment
with IFN-g alone had no effect on NO production (in
both WT and MyD88-/- BMMj) even with IL-4 treat-
ment (Figure 1B).
MyD88-deficiency of has no effect on arginase-1, RELMa,
and Ym1 expression in BMMjs
To ascertain further the phenotype of the AAMjse l i -
cited by the F. hepatica infection, the gene expression of
AAMj markers arginase-1, RELMa,a n dY m 1i n
BMMj were measured via real-time reverse transcrip-
tase polymerase chain reaction (RT-PCR). The results
show no deficiency in AAMjgeneration in the
MyD88-/- animals. Figure 2 shows that arginase-1
expression in MyD88-/- BMMj treated with IL-4 was
lower than that of WT BMMj, and no expression on
both untreated WT and MyD88-/- BMMj. The expres-
sion profiles of both RELMa and Ym1 in the BMMjs
show similar trends with higher levels on the MyD88-/-
BMMj treated with IL-4; however, no statistically signif-
icant differences were found (Figure 2).
The Th2 cytokine bias is not significantly altered in F.
hepatica-infected mice in the absence of MyD88 in vitro
and in vivo
Ascertaining any effects on the overall Th2 response in
F. hepatica-infected mice is essential before determining
the effect of MyD88 knockdown on macrophage activa-
tion in vivo. Consequently, the Th2 cytokines IL-4, IL-5,
IL-10, and IL-13, together with IFN-g,am a r k e ro fT h 1
response, were monitored in the supernatant fluids of
cultured splenocytes treated with media, anti-CD3, or
FhAg (Figures 3A-3E). The results showed that all Th2
cytokines were elevated on FhAg stimulation in the
infected WT mice and were further increased in the
MyD88-/- infected mice, although no statistically signifi-
cant difference was found between the WT and
MyD88-/- infected mice. In contrast, the Th1 response,
as measured with IFN-g decreased significantly upon
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Page 2 of 11stimulation with FhAg or anti-CD3 but not media in the
infected MyD88-/- mice compared with the WT
infected mice (Figure 3E). Meanwhile, the thioglycolate-
injected WT and MyD88-/- mice exhibited low levels of
b o t hT h 1a n dT h 2c o m p a r e dw i t ht h e i ri n f e c t e dc o u n -
terparts. The local cytokine production in the PEC
supernatant fluid (Figures 4A-4E) was also measured.
Significantly higher IL-4 levels were observed in the
MyD88-/- infected mice compared with both the WT
and the WT-infected mice (Figure. 4 A). Similar trends
were seen in cytokine IL-5 and IL-13 (Figures 4B and
4C). However, no statistically significant difference in
IL-10 production was found between the WT and
MyD88-/- mice in both the thio and infection treat-
ments. In contrast, the IFN-g in the both MyD88-/- thio
and the MyD88-/- infected mice significantly decreased
compared with that in THE F. hepatica-infected WT
mice. Overall, these results show that the Th2 response
i sn o ti m p a i r e di nF. hepatica-infected MyD88-/- mice
both in vitro and vivo.
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Figure 1 The absence of MyD88 has no effect on the AAMjs derived from bone marrow in vitro.T h eB M M j were treated with or
without IL-4 followed by the stimulation with LPS and IFN-g together or separately for 12-24 h. (A). The urea concentration represents the
arginase activity after the stimulation. (B). The nitrite concentration is shown as a measure of iNOS activity produced by the BMMjs. Five mice
were tested per group. Results are compiled from three independent experiments.
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Figure 2 MyD88-deficiency did not impair arginase-1, RELMa, and Ym1 expression in BMMjs. mRNA was extracted and real-time RT-PCR
for arginase-1, RELMa, and Ym1 expression was carried out to examine AAMj generation. The black bars represent the mRNA expression in
mice treated with IL-4. The mRNA expression is shown as a percent of the positive control sample and b-actin was used to normalize the
experiments. Results are compiled from three independent experiments.
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Figure 3 The Th2 cytokine production bias in splenocytes was not significantly altered in the F. hepatica-infected mice in the absence
of MyD88 in vitro. Splenocytes collected from C57BL/6 mice were stimulated with media alone, anti-CD3, or F. hepatica antigen (FhAg) for 72
h. The levels of IFN-g, IL-4, IL-5, IL-10, and IL-13 in the supernate were measured indirectly via ELISA. The statistical significant differences were
determined via one-way ANOVA followed by a Kruskal-Wallis test. *p < 0.05. Five mice were tested per group. Results are compiled from three
independent experiments.
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Figure 4 The Th2 cytokine production bias in the pleural cavity lavage was not significantly altered in the MyD88-deficient F.
hepatica-infected mice. Peritoneal exudate cells (PEC) were collected from the C57BL/6 mice and were treated with media alone, anti-CD3, or
F. hepatica antigen (FhAg) for 72 h. The levels of IFN-g, IL-4, IL-5, IL-10, and IL-13 in the supernate were measured indirectly via ELISA. Statistical
significances were determined via one-way ANOVA followed by a Kruskal-Wallis test. * p < 0.05 and ** p < 0.01. Five mice were tested per
group. Results are compiled from three independent experiments.
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Page 4 of 11MyD88-deficiency did not affect the arginase production
of the F. hepatica-elicited macrophages in PECs
To determine whether MyD88-deficiency affects produc-
tion in macrophages recruited in PEC, the arginase
activity levels were measured using the purified macro-
phages from the PEC (Figure 5). As shown, macro-
phages from F. hepatica-infected mice produced more
arginase than macrophages from the mice treated with
thioglycolate, and the MyD88-/- and WT infected mice
produced significantly higher arginase than the
MyD88-/- thio mice, although no difference was seen
between the WT thio and the WT infected mice. In
addition, no significant difference in arginase levels was
observed between the WT and MyD88-/- infected mice.
The absence of MyD88 had no effect on RELMa and Ym1
production by cells in the peritoneal cavity after F.
hepatica infection
We investigated whether the absence of MyD88 impairs
RELMa and Ym1 expression in peritoneal lavage fluid
using western blot analysis (Figures 6A and 6B) and
real-time RT-PCR (Figure 7). As shown in the figure,
although both the RELMa and Ym1 protein signals
were detected in the WT and the MyD88-/- infected
mice, no significant difference was found between these
two groups. To determine whether the mRNA expres-
sion levels correlates with protein production, total
RNA was extracted from purified macrophages in the
peritoneal cavity and real-time RT-PCR was performed
to detect RELMa,Y m 1 ,a n da r g i n a s e 1m R N Ae x p r e s -
sion (Figures 7A and 7B). Although WT and MyD88-/-
infected mice produced detectable RELMa and Ym1,
they could not be detected in the WT and MyD88-/-
thio mice. No statistically significant difference in
RELMa and Ym1 mRNA expression was observed
between the WT and the MyD88-/- infected mice,
which is consistent with the protein profiles of RELMa
and Ym1 above.
Discussion
The data demonstrates that macrophages from a chronic
infection, which consequently produce Th2 type cyto-
kines at the stage wherein young F. hepatica penetrates
the liver capsule and migrates through the liver tissue,
do not require TLR signaling for AAMF induction.
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Figure 5 MyD88-deficiency has no effect on arginase
production of the F. hepatica-elicited macrophage (FeMj). Six
weeks after F. hepatica infection, macrophages were purified from
the PEC by adherence and the levels of arginase activity were
measured. Thioglycolate (thio) was also injected as the control.
Significant differences were determined via one-way ANOVA
followed by a Kruskal-Wallis test. *p < 0.05 and ** p < 0.01. Results
are compiled from three independent experiments.
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Figure 6 The Absence of MyD88 had no effect on the production of RELMa and Ym1 proteins by cells in the peritoneal cavity after F.
hepatica infection. Six weeks after F. hepatica infection of C57BL/6 mice, peritoneal cavity lavages were performed and western blots for RELMa
(A) and Ym1 (B) were carried out on the lavage fluid. Image software was used to measure the relative concentrations of proteins on the blots.
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Page 5 of 11Like many other helminths, to establish successful
chronic infections, F. hepatica induces Th2 responses
characterized by increased IL-4, IL-5, and IL-13, activa-
tion and expansion of eosinophils, CD4
+cells, basophils,
and mast cells [8-10,13,34-39]. Simultaneously, hel-
minths release excretory-secretory proteins (ESP) to pre-
vent dendritic cells and macrophages from acting on
TLR2 Th1-stimulating ligands such as LPS and CpG
during infections [40-42]. For example, cathepsin L1
cysteine protease released by F. hepatica suppresses the
macrophage TLR recognition of LPS [43]. However, dif-
ferent infective stages may develop diverse immune
responses. For instance, cytotoxic natural killer (CNK)
cells dominate in the peritoneal fluid of F. hepatica-
infected rats as early as 2 days post infection (p. i.).
However, the cells decreased 4 days p.i. [44]. Therefore,
the experimental set-up depends on the response out-
comes needed. According to the life cycle of F. hepatica,
the juvenile flukes penetrate the liver capsule and
migrate through the liver tissue at 6 to 7 weeks before
entering the bile ducts. This stage is rigorous for the
host because of the violent penetration and migration of
flukes. In addition, most activity detections of macro-
phages focus on the early stage of F. hepatica infection
[14,45,46]; thus, little is known about the AAMF at 6
weeks post F. hepatica infection, which is the reason
why the AAMF phenotype in MyD88 deficient mice at
this stage needs to be addressed.
The data demonstrates that the absence of MyD88
does not impair the Th2 response in F. hepatica-
infected mice compared with the infected WT mice
when the splenocytes in vitro were stimulated with
FhAg. Furthermore, a non-statistically significant
increase toward the Th2 response was also found in
between. Moreover, the in vivo experiments also show
that IL-4, IL-5, and IL-13 on MyD88-/- infected mice
were significantly higherc o m p a r e dw i t ht h eW Ta n d
WT-infected mice. In contrast, the IFN-g in both the
MyD88-/- thio and the MyD88-/- infected mice were
significantly decreased compared with that in F. hepa-
tica-infected WT mice, which indicates that a Th2-
dominant response was induced in vivo.T h i si sc o n s i s -
tent with the previous studies that provide evidence of
elevated Th2 responses when MyD88-deficient mice
were infected with Leishmania major [30,47], Chlamy-
dia muridarum [48], or Schistosoma mansoni [49,50].
Similarly, MyD88 -/- mice infected with the gastrointest-
inal nematode Trichuris muris exhibited high resistance
to infection and displayed an increase in IL-4 and IL-13
in cultured mesenteric lymph node cells with stimula-
tion of T. muris specific antigen in vitro [51] compared
with their WT counterparts. However, this was argued
to be associated with powerful Th1 stimuli via a
MyD88-dependent pathway because of the presence of
commensal bacteria, which indicates the Th2 response
to nematodes might be impaired because of increased
Th1 response [52]. This is supported by experiments on
S. mansoni showing that the absence of MyD88 sup-
ports Th2 responses [50]. However, in the present
study, F. hepatica infection was not yet reported to
carry any bacteria, which may mount a Th1 response.
Therefore, no significant augmentation was seen in the
MyD88 deficient mice. However, the Th2 response was
clearly induced in the WT mice and mice lacking
MyD88 with F. hepatica infection. As demonstrated by
previous studies, Th2 response induced by helminth
infections contribute to AAMF production (reviewed in
[53]), F. hepatica infection may promote AAMF. This is
supported by the fact that AAMF could be produced by
FhAg combined with IL-4 and stimulation with FhAg
together with LPS (as a stimulus for TLR4 activity) or
purified protein derivative from Mycobacterium bovis
(PPD-B, as a stimulus for TLR2 activity) in WT mice
resulted in reduced NO or IFN-g production,
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Figure 7 The lack of MyD88 has no effect on Ym1 and RELMa mRNA expression of macrophages from the peritoneal cavity. Six weeks
after F. hepatica infection of C57BL/6 mice, the peritoneal cavity lavages were collected and macrophages were purified. RNA extraction and real-
time RT-PCR were used for detection of RELMa (A) and Ym1 (B). mRNA expression is shown as a percent of the positive control sample and b-
actin was used to normalize the experiments.
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Page 6 of 11respectively [54]. Also, the thioredoxin peroxidase (TPX)
secreted by F. hepatica induced the AAMF on cell lines
in vitro [14,15]. Along with the present study, an impli-
cation that MyD88 deficiency is dispensable to the
AAMj may be reached.
The present study implies that MyD88 is not required
for Th2 response and AAMj activation. In WT BMMj,
arginase production increased on treatment with LPS,
which signals through the TLR4 pathway, which is con-
sistent with the reports that LPS helps induce the pro-
duction of both arginase isoforms (arginase-1 and
arginase-2) [32,55]. Further, the arginase activity in
MyD88-/- BMMj, treated with the media, LPS, IFN-g,
or both was almost absent, indicating that this activity is
MyD88-independent. In both the WT and MyD88-/-
BMMj, arginase mRNA increased upon treatment with
IL-4, which is in agreement with the reports that argi-
nase could be induced when stimulated with IL-4 [56]
Similar trends were seen in the production of RELMa
and Ym1 mRNA in WT and MyD88-/- BMMj in
response to IL-4. These findings offering further evi-
dence that AAMj is induced in MyD88 deficient mice.
On the other hand, NO was produced synergistically by
MyD88-/- BMMj when stimulated with both LPS and
IFN-g together, whereas it was produced by WT BMMj
when treated with LPS alone. The NO produced by
macrophages is essential to the suppression of host
cytotoxicity and its production may be MyD88-depen-
dent or -independent. In the present study, LPS signals
through the TLR4 via the IRF-3 pathway during
MyD88-deficiency, resulting in an increase in IFNb
instead of iNOS. IFNb then induces IRF-1 production,
which leads to the production of NO with the help of
IFN-g. This was supported by Koide et al.[ 5 7 ] ,w h o
showed that the LPS-dependent increase in iNOS
mRNA expression induced by IFN-g is attributed to the
IRF-1 upregulation induced by LPS. Moreover, iNOS
cannot be induced by IFN-g alone because of the lack of
IRF-1 in the absence of MyD88. However, this specula-
tion was not yet investigated.
Considering no significant difference was found in the
Th2 cytokine profiles between the WT and MyD88-defi-
cient mice, the lack of MyD88 may have affected the
production of macrophages. However, the arginase
activity in the macrophages from the PEC were at
approximately the same level in the WT and MyD88-/-
AAMjs (Figure 5) despite both being significantly
higher than those in MyD88 -/- thio AAMjs. RELMa
and Ym1 Protein expression in the peritoneal cavity
were not impaired with the MyD88-deficiency (Figure 6)
and the mRNA expression of both genes (Figure 7)
retained the same profiles as the protein expression,
respectively. However, some effects on the response to
thioglycolate treatment of the MyD88-deficient mice
were observed, which indicates the partial role of TLR
stimulus in thioglycolate-induced macrophage pheno-
type. These findings may be related to the mixture of
TLR ligands in thioglycolate, which might have been
ignored when the actual function of thioglycolate in
macrophage activation was analyzed. All of these find-
i n g ss u p p o r tt h a tM y D 8 8i sn o tr e q u i r e df o rm a c r o -
phage activation during F. hepatica infection.
Conclusion
In summary, MyD88 is not required for AAMj induc-
tion in vitro and in vivo. In addition, the Th2 cytokine
profile remained intact in the MyD88-deficient mice
infected with the F. hepatica 6 weeks post infection.
Methods
Mice and infection
All animal experiments were carried out in the Animal
Care and Ethics Center. Female C57BL/6 mice (6-7
weeks old) were purchased from Slaccas Experimental
Animal Company. MyD88-/- mice were bred at the
experimental animal center and were in the 5th and 6th
generation of backcross to C57BL/6 mice. All mice were
raised with free access to tap water and standard rodent
diet under a pathogen-free- environment. All mice were
maintained based on the Institutional and National
Institutes of Health guidelines.
The wild type (WT) and Myd88-/- mice with C57BL/6
background were infected orally with 45 Faciola hepa-
tica metacercariae. The metacercariae were collected
from miracidia-infected Galba truncatula snails. All
mice were euthanized 10 weeks post infection and the
peritoneal exudate cells (PEC) were harvested by lava-
ging the peritoneal cavity with 10 mL ice-cold Dulbec-
co’s modified Eagle’sm e d i u m( D M E M )( G i b c o )f o r
mRNA extraction, western blotting, and/or cytokine
analysis. The spleen was used for cell culture, which was
used for the detection of cytokines in vitro.T h e n ,0 . 6
mL of 5% thioglycolate medium (Becton Dickinson) per
mice were injected as the non-Th2 polarized inflamma-
tion control.
Activation of BMMj
The BMMjs from the C57BL/6 mice were harvested
from the bone marrow in the femur and tibia. Macro-
phage differentiation was carried out based on previous
literature [58]. Briefly, erythrocytes were treated with 3
mL red blood cell lysis buffer (Sigma-Aldrich) for 5 min.
The cells were cultured at 5 × 10
6 cells per plate in
DMEM with 20% Fetal Calf Serum (FCS) (GIBCO), 20%
L929 supernatant, 2 mM L-glutamine, 0.25 U/mL peni-
cillin, and 100 μg/mL streptomycin. The medium was
replaced to obtain pure macrophages at six days post
culture. The collected BMMj were stored in fresh Petri
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Pharmingen) followed by treatment with LPS (100 ng/
mL; Escherichia coli 0111:B4, Sigma-Aldrich) and IFN-g
(10 U/mL; BD Pharmingen) for 20-24 h together or
separately.
Measurement of Nitric Oxide (NO)
NO was detected via nitrite accumulation in the macro-
phage culture media using Greiss Reagent (Sigma-
Aldrich). Briefly, 100 μL of the supernatant fluid and
100 μL of 5.8% phosphoric acid (Sigma-Aldrich), 1% sul-
fanilamide (Sigma-Aldrich), 0.1% N-(1-naphthyl) ethyle-
nediamine dihydrochloride (Sigma-Aldrich) were briefly
mixed. The absorbance was read at 540 nm on a micro-
plate reader. The NO concentration was determined
based on a standard sodium nitrite solution curve.
Determination of arginase activity
Arginase activity was measured according to the pre-
vious literature [23]. Briefly, 1 × 10
5 macrophage cells
were treated with 100 μL 0.1% Triton X-100 (Sigma-
Aldrich) and 100 μLo f2 5m MT r i s - H C L( S i g m a -
Aldrich). After a 30-min shaking incubation, 20 μLo f
10 mM MnCl2 (Sigma-Aldrich) was added. Then, the
cells were heated at 56°C for 10 min to activate the
enzyme and 100 μL of this lysate with 100 μLo f0 . 5M
L-arginine (pH 9.7, Sigma-Aldrich) was incubated at 37°
C for 60 min to examine the L-arginine hydrolysis. The
reaction was stopped with addition of 800 μLo fH 2SO4
(96%)/H3PO4 (85%)/H2O (1/3/7, v/v/v), and 40 μLo f9 %
isonitroso-propiophenone (Sigma-Aldrich). The cells
were then heated at 99°C for 30 min. The plates were
read at 540 nm on a microplate reader. Arginase
enzyme activity was determined based on a standard
urea solution curve.
Preparation of F. hepatica antigens
Fresh F. hepatica adults from infected mice were
washed with phosphate-buffered saline (PBS, pH 7.3)
solution. The worms were homogenized with 10 mM
Tris-HCl (pH 7.2), 150 mM EDTA at 4°C and sonicated
on ice for 5 min. The homogenates were centrifuged at
12,000 × g at 4°C for 1 h. The supernatant fluids were
harvested as F. hepatica extracted antigen (FhAg). The
protein concentrations were detected using a BCA pro-
tein assay kit (Invitrogen, UK).
Cell culture and stimulation
Splenic cells and PECs were cultured in vitro.T h e
spleens were crushed and the cells were centrifuged at
1100 × g for 5 min, and then resuspended at 5 × 10
6/
mL. The supernatant fluid was abandoned after the
addition of 3 mL of RBC Lysis Buffer (Sigma). The cells
were centrifuged at 1100 × g for 5 min followed by a
final re-suspension at 10
7/mL with the addition of 10
mL of RPMI 1640. The cells were dispensed at 5 × 10
5
cells per well. A final volume of 200 μL of splenic cells
in triplicate were cultured with FhAg (10 μg/mL), RPMI
1640 media and anti-CD3 (1 μg/mL) at 37°C in 5% CO2
for 48 h, followed by the addition of 10% of total
volume Alamar Blue (Invitrogen, UK) for another 24 h.
The plates were read at 540 nm for cell proliferation
and the supernatant fluids were harvested and kept at
-20°C for further cytokine analyses after centrifugation
at 1100 × g for 2 min. PEC culture and stimulation
were performed similar to that for the splenocytes
above.
Cytokine determination
IL-4, IL-5, IL-10, IL-13, and IFN-g in the spleen and PEC
supernatant fluid were detected by sandwich ELISA. The
plates were coated with carbonate-buffered capture anti-
bodies at 50 μL/well (the dilution factor was 1:500 for IL-
4, IFN-g and 1: 250 for IL-5, IL-10, and IL-13) and incu-
bated overnight at 4°C. The plates were incubated in 4%
BSA PBS (200 μL/well) for 2 h at room temperature in
the dark, followed by addition of 50 μL/well 2-fold
diluted standard antibodies (top concentration: IL-4 at 8
ng/mL; IL-5, IL-10, and IL-13 at 10 ng/mL; IFN-g at 50
ng/mL diluted with 1% BSA PBS) in duplicate after wash-
ing. Then, 50 μL/well of the spleen or PEC supernatant
samples were then added and incubated overnight at 4°C,
followed by incubation in biotinylated antibodies (final
dilution: IL-4, IL-5, IFN-g at 1 μg/mL; IL-10 and IL-13 at
2 μg/mL in 1% BSA PBS) for 1 h at room temperature
and AMDEX streptavidin-peroxidase (Sigma, France) at
dilution 1: 6000 in 1% BSA PBS for 30 min. Finally, 50
μL/well of TMB (KPL) was added and reaction was
stopped with the addition of 50 μL of 1 mM H2SO4.T h e
absorbance was read at 450 nm.
Relative quantification of genes
The expression of arginase-1, RELMa, and Ym-1 genes
were quantified via real-time RT-PCR. Total RNA was
extracted according to the manufacturer’s instructions.
Approximately 1 μgo ft h et o t a lR N Aw a su s e dt o
synthesize cDNA using MMLV reverse transcriptase
(Stratagene). Then, the relative quantification of the
genes was determined using a Light Cycler (Roche
Molecular Biochemicals). A cDNA (FeMj)-positive con-
trol sample with five serial (1:4) dilutions was used as
the standard curve in each reaction. b-Actin was used to
normalize the expression of the test genes. A 10 μL
reaction containing 1 μLc D N A ,4m MM g C l 2,0 . 3m M
primers, and the Light Cycler-DNA SYBR Green I mix
was carried out under the following conditions: dena-
turation at 95°C for 40 s, annealing at 54°C for 10 s, and
elongation at 72°C for 15 s, 45-55 cycles. The annealing
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for light cycler PCR analysis are listed in Table 1.
Western blot analysis
Up to 20 μL of the peritoneal cavity lavage fluid was
mixed with LDS sample loading buffer (NuPAGE) and
heated to resolve by SDS-PAGE using 4%-12% NuPAGE
gel. The proteins were transferred from the gel onto a
cellulose nitrate membrane by electrophoresis at 30 V
for 1 h. Then, the membranes were incubated for 1 h in
5% skimmed milk in TBS and incubated with Anti-Ym1
(produced by immunization of the mice with recombi-
nant protein, diluted in 5% skimmed milk in TBS block-
ing buffer: 1/3000) and anti-RELMa (produced by
immunization of the mice with recombinant protein, 1/
500) antibodies separately after 1 h block, followed by
incubation with goat anti-mouse IgG alkaline phospha-
tase conjugate (1:5000) for 8 h. Then, it was incubated
with the substrate (specify) Chemi Glow (luminol/
enhancer solution: stable peroxide buffer = 1:1) until the
color developed. The reaction was ceased by absorption
of the rest of substrates. The results were recorded
using the Gel Image System (Bio-Rad). Image software
was used to measure the relative concentrations of pro-
teins on the blots.
Statistical analysis
One-way ANOVA was applied to evaluate the statistical
differences between groups. The non-parametric Kruskal-
Wallis rank sum test along with Dunn’s test was applied
on all analyses. Differences with P < 0.05 were considered
significant. The values are presented as mean ± SE unless
otherwise stated. All graphs were made using PRISM soft-
ware (version 5.0, GraphPad Software, Berkeley, CA).
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